INVENT.INTEGRATE.INNOVATE. Trademark

Trademark Overview

On Wednesday, March 5, 2003, a trademark application was filed for INVENT.INTEGRATE.INNOVATE. with the United States Patent and Trademark Office. The USPTO has given the INVENT.INTEGRATE.INNOVATE. trademark a serial number of 78222136. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, August 17, 2010. This trademark is owned by Angiotech Pharmaceuticals, Inc.. The INVENT.INTEGRATE.INNOVATE. trademark is filed in the Pharmaceutical Products category with the following description:

a full line of pharmaceuticals; pharmaceuticals, namely, therapeutic agents for the treatment of angiogenesis-related diseases, chronic inflammatory diseases, multiple sclerosis, psoriasis, arthritis and surgical adhesions and cardiovascular grafts
invent.integrate.innovate.

General Information

Serial Number78222136
Word MarkINVENT.INTEGRATE.INNOVATE.
Filing DateWednesday, March 5, 2003
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, August 17, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesa full line of pharmaceuticals; pharmaceuticals, namely, therapeutic agents for the treatment of angiogenesis-related diseases, chronic inflammatory diseases, multiple sclerosis, psoriasis, arthritis and surgical adhesions and cardiovascular grafts
Pseudo MarkINVENT INTEGRATE INNOVATE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 28, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAngiotech Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver V6A 1B6

Trademark Events

Event DateEvent Description
Wednesday, August 18, 2010ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, August 17, 2010ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, January 12, 2010NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, January 12, 2010INQUIRY TO SUSPENSION E-MAILED
Tuesday, January 12, 2010SUSPENSION INQUIRY WRITTEN
Tuesday, December 22, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Sunday, June 21, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, June 21, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, June 19, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Saturday, December 6, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, May 29, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, November 29, 2007REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, May 23, 2007REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, November 21, 2006REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, November 21, 2006ASSIGNED TO LIE
Tuesday, October 24, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 29, 2006REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, September 9, 2005REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, September 9, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 30, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 30, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 2, 2005INQUIRY TO SUSPENSION E-MAILED
Wednesday, March 2, 2005SUSPENSION INQUIRY WRITTEN
Monday, August 30, 2004REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, March 11, 2004EMAIL RECEIVED
Thursday, March 11, 2004LETTER OF SUSPENSION E-MAILED
Wednesday, February 18, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 18, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 18, 2003NON-FINAL ACTION E-MAILED
Monday, August 18, 2003ASSIGNED TO EXAMINER

Related Keywords

innovate integrate invent pharmaceuticals diseases psoriasis sclerosis multiple arthritis surgical grafts cardiovascular adhesions